Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Lyophilized powder for conventional release solution for injection (dose form) |
Is a |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely degarelix 80 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely degarelix 120 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely temozolomide 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Cefazolin (as cefazolin sodium) 10 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely cefazolin (as cefazolin sodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
cefmetazolnatrium 2 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
bensylpenicillin, bensatin 150 000 IE och bensylpenicillin, prokain 150 000 IE, pulver till injektinsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
bensylpenicillin, bensatin 900 000 IE och bensylpenicillin, prokain 300 000 IE, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely Varicella-zoster virus antibody 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
humant immunglobulin mot hepatit B 200 IE, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely mitomycin 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely bleomycin (as bleomycin sulfate) 30 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
humant immunglobulin mot hepatit B 500 IE, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Anidulafungin 50 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
cefmetazolnatrium 1 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely ampicillin (as ampicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Trastuzumab 440 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely telavancin (as telavancin hydrochloride) 750 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
hydrokortison 100 milligram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Telavancin (as telavancin hydrochloride) 250 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely cefotetan (as cefotetan disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Hyaluronidase 1500 unit powder for solution for injection ampule |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
warfarin 2 mg/ml, pulver till injektionsvätska, lösning |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely cefotetan (as cefotetan disodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely mitomycin 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Streptomycin (as streptomycin sulfate) 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely pemetrexed (as pemetrexed disodium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
metronidazolhydroklorid 500 mg, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
digoxinspecifik antikropp 38 mg, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
alfa-1-antitrypsin 1000 mg, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
cefapirinnatrium 1 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Agalsidase beta 5 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
natriumnitroprussiddihydrat 50 milligram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
cefazolin 250 mg, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
immunglobulin varicella-zoster 125 IE, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
dinatriumcefotetan 10 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
ceftazidim (som ceftazidimpentahydrat) 3 gram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Aztreonam 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
tikarcillin 3 g + klavulansyra 100 mg, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
L-asparaginas 10 000 IE, pulver till injektionsvätska, flaska 10 ml |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Aztreonam 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
metajodbensylguanidin (^131^I) 35 MBq/ml, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
natriumjodid (^131^I) 37-7 400 MBq, pulver för beredning av injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely ampicillin (as ampicillin sodium) 2 gram and sulbactam (as sulbactam sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
faktor VIII, 500 enheter + von Willebrandfaktor, 1 250 IE, pulver till injektionsvätska, lösning |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
azatioprin 50 milligram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
6-jodometylnorkolesterol (^131^I) 8-30 MBq/ml, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Amoxicillin (as amoxicillin sodium) 1 g and clavulanic acid (as clavulanate potassium) 200 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Nafcillin (as nafcillin sodium) 2 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
doripenem (som doripenemmonohydrat) 500 milligram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
kromfosfat (^32^P) 185 MBq/ml, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
metajodbensylguanidin (^123^) 74 MBq/ml pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
gentamicin 1 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely cefepime (as cefepime hydrochloride) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
humant koriongonadotropin, 10000 IE, pulver och vätska till injektionslösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
polymyxin B-sulfat 500 000 IE, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
faktor VIII, 1000 IE + von Willebrandfaktor, 2 500 IE, pulver till injektionsvätska, lösning |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
bacitracin 5 000 000 enheter, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
ceftazidim (som ceftazidimpentahydrat) 250 milligram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Aztreonam 2 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
renium(^186^Re)etidronat 1,3 GBq/ml, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
tikarcillindinatrium 1 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely dactinomycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
pantoprazol (som pantoprazolnatriumseskvihydrat) 40 milligram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
rilonacept 220 mg, pulver till injektionsvätska, flaska 20 ml |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely cefazolin (as cefazolin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
natriumcefoxitin 10 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely romiplostim 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Cefazolin (as cefazolin sodium) 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely bleomycin (as bleomycin sulfate) 15 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
urokinas 250 000 IE, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
urea 40 g, pulver till injektionsvätska, flaska 200 ml |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely cefoxitin (as cefoxitin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
tikarcillindinatrium 20 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely cefamandole (as cefamandole nafate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
folinsyra 15 mg, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
folinsyra 30 mg, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Amobarbital sodium 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Capreomycin (as capreomycin sulfate) 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
tikarcillindinatrium 3 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
azitromycin (som azitromycindihydrat) 500 milligram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Palifermin 6.25 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Chlorothiazide 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
meropenem (som meropenemtrihydrat) 1 gram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
abatacept 250 mg, pulver till injektionsvätska, flaska 15 ml |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
faktor IX-koncentrat, 1 000 IE, pulver till injektionsvätska, lösning, flaska 20 ml |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Remifentanil (as remifentanil hydrochloride) 2 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
tyreotropin alfa 0,9 mg/ml, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely remifentanil (as remifentanil hydrochloride) 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely cefamandole (as cefamandole nafate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
meropenem (som meropenemtrihydrat) 500 milligram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Human alpha1 proteinase inhibitor 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
piperacillin 1 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Pentamidine isetionate 300 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
natriumceftizoxim 1 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely ampicillin (as ampicillin sodium) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|